Extracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: Role in engraftment

Bone Marrow Transplantation

Volumn 46, Issue 10, 2011, Pages 1382-1388

  Bethge, W A ^a,b   Kerbauy, F R ^a,c   Santos, E ^a   Gooley, T A ^a   Storb, R ^a   Sandmaier, B M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University Hospital of Tuebingen   (Germany)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

engraftment; hematopoietic cell transplantation; pentostatin; photopheresis

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DOG; ENGRAFTMENT; EXTRACORPOREAL PHOTOPHERESIS; GRAFT REJECTION; HEMATOPOIETIC CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PHOTOTHERAPY; PRIMARY PREVENTION; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ANIMALS; DOGS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS; IMMUNOMODULATION; PENTOSTATIN; PHOTOPHERESIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 80053949492     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.301     Document Type: Article

References (47)

1. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997; 89: 3048-3054. (Pubitemid 27172593)
2. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390-3400.
3. Panse JP, Storb R, Storer B, Santos EB, Wentzel C, Sandmaier BM. Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation. Transplantation 2005; 80: 1518-1521. (Pubitemid 41803637)
4. Hogan WJ, LittleM-T, Zellmer E, Friedetzky A, Diaconescu R, Gisburne S et al. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. Biol Blood Marrow Transplant 2003; 9: 489-495. (Pubitemid 38351793)
5. Sorror ML, Leisenring W, MielcarekM, Baron F, Diaconescu R, Hogan WJ et al. Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation. Transplantation 2008; 85: 1023-1029. (Pubitemid 351543167)
6. Zic JA, Stricklin GP, Greer JP, Kinney MC, Shyr Y, Wilson DC et al. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. J Am Acad Dermatol 1996; 35: 935-945. (Pubitemid 26422118)
7. Berger CL. Experimental murine and primate models for dissection of the immunosuppressive potential of photochemotherapy in autoimmune disease and transplantation (Review). Yale Journal of Biology & Medicine 1989; 62: 611-620. (Pubitemid 20201941)
8. Dall'Amico R, Rossetti F, Zulian F, Montini G, Murer L, Andreetta B et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 1997; 97: 848-854. (Pubitemid 27321387)
9. Foss FM, Gorgun G, Miller KB. Extracorporeal photopheresis in chronic graft-versus-host disease (Review). Bone Marrow Transplant 2002; 29: 719-725. (Pubitemid 34624559)
10. Giunti G, Schurfeld K, Maccherini M, Tanganelli P, Rubegni P, Alfani D et al. Photopheresis for recurrent acute rejection in cardiac transplantation. Transplant Proc 1999; 31: 128-129. (Pubitemid 29127391)
11. Horina JH, Mullegger RR, Horn S, Holzer H, Halwachs G, Kerl H et al. Photopheresis for renal allograft rejection. Lancet 1995; 346: 61.
12. Oliven A, Shechter Y. Extracorporeal photopheresis: a review (Review). Blood Rev 2001; 15: 103-108.
13. Greinix HT, Volc-Platzer B, Rabitsch W, Gmeinhart B, Guevara-Pineda C, Kalhs P et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998; 92: 3098-3104. (Pubitemid 28492315)
14. Brogden RN, Sorkin EM. Pentostatin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders. Drugs 1993; 46: 652-677. (Pubitemid 23331064)
15. Chan GW, Gorgun G, Miller KB, Foss FM. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 170-176.
16. Chan GW, Foss FM, Klein AK, Sprague K, Miller KB. Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graftversus-host disease. Biol Blood Marrow Transplant 2003; 9: 753-759. (Pubitemid 38145744)
17. Pavletic SZ, Bociek RG, Foran JM, Rubocki RJ, Kuszynski CA, Wisecarver JL et al. Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation. Transplantation 2003; 76: 877-881. (Pubitemid 37140238)
18. Miller KB, Roberts TF, Chan G, Schenkein DP, Lawrence D, Sprague K et al. A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease. Bone Marrow Transplant 2004; 33: 881-889. (Pubitemid 38660120)
19. Wagner JL, Burnett RC, Works JD, Storb R. Molecular analysis of DLA-DRBB1 polymorphism. Tissue Antigens 1996; 48: 554-561. (Pubitemid 27007295)
20. Wagner JL, Burnett RC, DeRose SA, Francisco LV, Storb R, Ostrander EA. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 1996; 62: 876-877. (Pubitemid 26332860)
21. Wagner JL, Works JD, Storb R. DLA-DRB1 and DLADQB1 histocompatibility typing by PCR-SSCP and sequencing (Brief Communication). Tissue Antigens 1998; 52: 397-401. (Pubitemid 28467017)
22. Ladiges WC, Storb R, Graham T, Thomas ED. Experimental techniques used to study the immune system of dogs and otherlarge animals. In: Gay WI, Heavener JE (eds). Methods of Animal Experimentation. Academic Press: New York, NY, 1989, pp 103-133.
23. Raff RF, Deeg HJ, Farewell VT, DeRose S, Storb R. The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells. Tissue Antigens 1983; 21: 360-373. (Pubitemid 13093899)
24. Loughran Jr TP, Deeg HJ, Storb R. Morphologic and phenotypic analysis of canine natural killer cells: Evidence for T-cell lineage. Cell Immunol 1985; 95: 207-217. (Pubitemid 16222349)
25. Yu C, Ostrander E, Bryant E, Burnett R, Storb R. Use of (CA)n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 1994; 58: 701-706. (Pubitemid 24317770)
26. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.
27. Foss FM. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation (Review). Semin Hematol 2006; 43: S35-S43.
28. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107: 235-242. (Pubitemid 26254840)
29. Bladon J, Taylor PC. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol 1999; 107: 707-711. (Pubitemid 30020139)
30. Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994; 14: 845-848.
31. Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006; 107: 3074-3080.
32. Perfetti P, Carlier P, Strada P, Gualandi F, Occhini D, van Lint MT et al. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant 2008; 42: 609-617.
33. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versushost disease. Blood 2002; 100: 941-947. (Pubitemid 34832621)
34. Tambur AR, Ortegel JW, Morales A, Klingemann H, Gebel HM, Tharp MD. Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transplant Proc 2000; 32: 747-748. (Pubitemid 30336721)
35. Alcindor T, Gorgun G, Miller KB, Roberts TF, Sprague K, Schenkein DP et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001; 98: 1622-1625.
36. Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+ Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007; 84: 31-39. (Pubitemid 47094638)
37. Di Renzo M, Sbano P, De Aloe G, Pasqui AL, Rubegni P, Ghezzi A et al. Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin Exp Immunol 2008; 151: 407-413. (Pubitemid 351160727)
38. Zaucha JM, Zellmer E, Georges G, Little M-T, Storb R, Storer B et al. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required. Biol Blood Marrow Transplant 2001; 7: 613-619. (Pubitemid 33130594)
39. Storb R, Yu C, Zaucha JM, Deeg HJ, Georges G, Kiem H-P et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 1999; 94: 2523-2529 (Pubitemid 29467702)
40. Jochum C, Beste M, Zellmer E, Graves SS, Storb R. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation. Biol BloodMarrow Transplant 2007; 13: 164-171. (Pubitemid 46112376)
41. Francisco LV, Langston AA, Mellersh CS, Neal CL, Ostrander EA. A class of highly polymorphic tetranucleotide repeats for canine genetic mapping. Mamm Genome 1996; 7: 359-362. (Pubitemid 126426671)
42. Reichert WL, Stein JE, French B, Goodwin P, Varanasi U. Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay. Carcinogenesis 1992; 13: 1475-1479.
43. Moore PF, Rossitto PV, Danilenko DM, Wielenga JJ, Raff RF, Severns E. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high density expression of CD4 by canine neutrophils. Tissue Antigens 1992; 40: 75-85.
44. Sandmaier BM, Storb R, Appelbaum FR, Gallatin WM. An antibody that facilitates hematopoietic engraftment recognizes CD44. Blood 1990; 76: 630-635. (Pubitemid 20251835)
45. Sandmaier BM, Schuening FG, Bianco JA, Rosenman SJ, Bernstein I, Goehle S et al. Biochemical characterization of a unique canine myeloid antigen. Leukemia 1991; 5: 125-130.
46. Denkers E, Badger CC, Ledbetter JA, Bernstein ID. Influence of antibody isotype on passive serotherapy of lymphoma. J Immunol 1985; 135: 2183-2186. (Pubitemid 16240056)
47. Jacobsen CN, Aasted B, Broe MK, Petersen JL. Reactivities of 20 anti-human monoclonal antibodies with leucocytes from ten different animal species. Veterinary Immunology & Immunopathology 1993; 39: 461-466. (Pubitemid 24023355)